The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
BLACR
Bellevue Life Sciences Acquisition Corp. Rights
Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Bellevue Life Sciences Acquisition Corp. Rights stock forecast from 0 analysts, the average analyst target price for Bellevue Life Sciences Acquisition Corp. Rights is not available over the next 12 months. Bellevue Life Sciences Acquisition Corp. Rights’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bellevue Life Sciences Acquisition Corp. Rights is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Bellevue Life Sciences Acquisition Corp. Rights’s stock price was USD 0.13. Bellevue Life Sciences Acquisition Corp. Rights’s stock price has changed by +1.64% over the past week, +0.00% over the past month and -43.48% over the last year.
No recent analyst target price found for Bellevue Life Sciences Acquisition Corp. Rights
No recent average analyst rating found for Bellevue Life Sciences Acquisition Corp. Rights
Company Overview Bellevue Life Sciences Acquisition Corp. Rights
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. Read Less
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare ...Read More
N/A
N/A
0
N/A
USD
USA
Adjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Rights (BLACR)
Loading...
Unadjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Rights (BLACR)
Loading...
Share Trading Volume for Bellevue Life Sciences Acquisition Corp. Rights Shares
Loading...
Compare Performance of Bellevue Life Sciences Acquisition Corp. Rights Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for BLACR
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Bellevue Life Sciences Acquisition Corp. Rights (Sector: )
Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock
Stock Target Advisor's fundamental analysis for Bellevue Life Sciences Acquisition Corp. Rights's stock is Neutral.
Unfortunately we do not have enough data on BLACR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BLACR's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BLACR's stock to indicate if its overvalued.
The last closing price of BLACR's stock was USD 0.13.
Unfortunately we do not currently have any market capitalization data for BLACR's stock.
Unfortunately we do not have enough analyst data on BLACR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bellevue Life Sciences Acquisition Corp. Rights's stock.
As per our most recent records Bellevue Life Sciences Acquisition Corp. Rights has 0 Employees.
Sorry we do not have any infomation available on Bellevue Life Sciences Acquisition Corp. Rights's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BLACR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
